258 related articles for article (PubMed ID: 17195076)
21. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
22. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
[TBL] [Abstract][Full Text] [Related]
23. MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5.
van Vliet SJ; Aarnoudse CA; Broks-van den Berg VC; Boks M; Geijtenbeek TB; van Kooyk Y
Eur J Immunol; 2007 Aug; 37(8):2075-81. PubMed ID: 17616966
[TBL] [Abstract][Full Text] [Related]
24. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
25. Sweet preferences of MGL: carbohydrate specificity and function.
van Vliet SJ; Saeland E; van Kooyk Y
Trends Immunol; 2008 Feb; 29(2):83-90. PubMed ID: 18249034
[TBL] [Abstract][Full Text] [Related]
26. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
27. Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
Freire T; Zhang X; Dériaud E; Ganneau C; Vichier-Guerre S; Azria E; Launay O; Lo-Man R; Bay S; Leclerc C
Blood; 2010 Nov; 116(18):3526-36. PubMed ID: 20720186
[TBL] [Abstract][Full Text] [Related]
28. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells.
Rughetti A; Pellicciotta I; Biffoni M; Bäckström M; Link T; Bennet EP; Clausen H; Noll T; Hansson GC; Burchell JM; Frati L; Taylor-Papadimitriou J; Nuti M
J Immunol; 2005 Jun; 174(12):7764-72. PubMed ID: 15944279
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
[TBL] [Abstract][Full Text] [Related]
30. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system.
Gustafsson A; Sjöblom M; Strindelius L; Johansson T; Fleckenstein T; Chatzissavidou N; Lindberg L; Angström J; Rova U; Holgersson J
Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492
[TBL] [Abstract][Full Text] [Related]
31. Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
Hong JC; Kim YS
Glycoconj J; 2000 Oct; 17(10):691-703. PubMed ID: 11425189
[TBL] [Abstract][Full Text] [Related]
32. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM
Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342
[TBL] [Abstract][Full Text] [Related]
33. Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells.
Pirro M; Schoof E; van Vliet SJ; Rombouts Y; Stella A; de Ru A; Mohammed Y; Wuhrer M; van Veelen PA; Hensbergen PJ
J Proteome Res; 2019 Mar; 18(3):1125-1132. PubMed ID: 30582698
[TBL] [Abstract][Full Text] [Related]
34. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
35. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
36. Targeting Tn-Antigen-Positive Human Tumors with a Recombinant Human Macrophage Galactose C-Type Lectin.
Bulteau F; Thépaut M; Henry M; Hurbin A; Vanwonterghem L; Vivès C; Le Roy A; Ebel C; Renaudet O; Fieschi F; Coll JL
Mol Pharm; 2022 Jan; 19(1):235-245. PubMed ID: 34927439
[TBL] [Abstract][Full Text] [Related]
37. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
[TBL] [Abstract][Full Text] [Related]
38. The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2).
da Costa V; van Vliet SJ; Carasi P; Frigerio S; García PA; Croci DO; Festari MF; Costa M; Landeira M; Rodríguez-Zraquia SA; Cagnoni AJ; Cutine AM; Rabinovich GA; Osinaga E; Mariño KV; Freire T
Cancer Lett; 2021 Oct; 518():72-81. PubMed ID: 34144098
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines.
Pirro M; Rombouts Y; Stella A; Neyrolles O; Burlet-Schiltz O; van Vliet SJ; de Ru AH; Mohammed Y; Wuhrer M; van Veelen PA; Hensbergen PJ
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129513. PubMed ID: 31911241
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
